Abstract
It has been reported that the cooperative binding of calcium ions indicated a local conformational change of the human cytosolic phospholipase A 2 (cPLA2) C2 domain (Nalefski et al., (1997) Biochemistry 36, 12011-12018). However its structural evidence is less known (Malmberg et al., (2003) Biochemistry 42, 13227-13240). In this letter, life-time decay and fluorescence quenching techniques were employed to compare the calcium-induced conformational changes. The life-time decay parameters and fluorescence quenching constant changes were small between the apo- and holo-C2 domains when tryptophan residue was excited at 295 nm. In contrast, the quenching constant change was large, from 0.52 M-1 for the apo-C2 to 8.8 M-1 for the holo-C2 domain, when tyrosine residues were excited at 284 nm. Our results provide new information on amino acid side chain orientation change at calcium binding loop 3, which is necessary for Ca2+ binding regulated membrane targeting of human cytosolic phospholipase A2.
Keywords: C2 domain, Cytosolic phospholipase A2, Fluorescence quench, Time-resolved fluorescence decay, Conformational change
Protein & Peptide Letters
Title: Ca2+ Binding Effects on the C2 Domain Conformation of Human Cytosolic Phospholipase A2
Volume: 13 Issue: 1
Author(s): B. Tan, S.- B. Qin, M.- E. Chen, H.- X. Cang and H.- J. Zhang
Affiliation:
Keywords: C2 domain, Cytosolic phospholipase A2, Fluorescence quench, Time-resolved fluorescence decay, Conformational change
Abstract: It has been reported that the cooperative binding of calcium ions indicated a local conformational change of the human cytosolic phospholipase A 2 (cPLA2) C2 domain (Nalefski et al., (1997) Biochemistry 36, 12011-12018). However its structural evidence is less known (Malmberg et al., (2003) Biochemistry 42, 13227-13240). In this letter, life-time decay and fluorescence quenching techniques were employed to compare the calcium-induced conformational changes. The life-time decay parameters and fluorescence quenching constant changes were small between the apo- and holo-C2 domains when tryptophan residue was excited at 295 nm. In contrast, the quenching constant change was large, from 0.52 M-1 for the apo-C2 to 8.8 M-1 for the holo-C2 domain, when tyrosine residues were excited at 284 nm. Our results provide new information on amino acid side chain orientation change at calcium binding loop 3, which is necessary for Ca2+ binding regulated membrane targeting of human cytosolic phospholipase A2.
Export Options
About this article
Cite this article as:
Tan B., Qin B. S.-, Chen E. M.-, Cang X. H.- and Zhang J. H.-, Ca2+ Binding Effects on the C2 Domain Conformation of Human Cytosolic Phospholipase A2, Protein & Peptide Letters 2006; 13 (1) . https://dx.doi.org/10.2174/092986606774502045
DOI https://dx.doi.org/10.2174/092986606774502045 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunological Disturbances and Neuroimaging Findings in Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD) Comorbid Patients
Current Topics in Medicinal Chemistry Dendritic Cell Homeostasis in the Regulation of Self-Reactivity
Current Pharmaceutical Design The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction
Drug Design Reviews - Online (Discontinued) Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer
Current Medicinal Chemistry Canine Nutritional Model: Influence of Age, Diet, and Genetics on Health and Well-Being
Current Nutrition & Food Science Probing the Neuro-psychological Changes Observed with the Administration of COVID-19 Drugs
Current Topics in Medicinal Chemistry Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Immunological Mechanisms of Interleukin-2 (IL-2) Treatment in HIV/AIDS Disease
Current Molecular Pharmacology Hydrogen Sulfide: From Physiology to Pharmacology
Inflammation & Allergy - Drug Targets (Discontinued) Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint Inhibitors
Current Cancer Drug Targets The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets Strontium Ranelate in Osteoporosis
Current Pharmaceutical Design Exploring Pharmacological Significance of Chalcone Scaffold: A Review
Current Medicinal Chemistry Antioxidant Food Supplements and Obesity-Related Inflammation
Current Medicinal Chemistry SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments
Infectious Disorders - Drug Targets Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Structural Characterization of Carbohydrates by Fourier Transform Tandem Mass Spectrometry
Current Proteomics Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update
Current Pharmaceutical Design Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Involvement of IL-1R/TLR Signalling in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Current Molecular Medicine